PUBMED FOR HANDHELDS

Journal Abstract Search


219 related items for PubMed ID: 3124536

  • 1. Treatment of corticoresistant idiopathic nephrotic syndrome in the adult: minimal change disease and focal segmental glomerulosclerosis.
    Meyrier A, Simon P.
    Adv Nephrol Necker Hosp; 1988; 17():127-50. PubMed ID: 3124536
    [Abstract] [Full Text] [Related]

  • 2. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
    Lee HY, Kim HS, Kang CM, Kim SG, Kim MJ.
    Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
    [Abstract] [Full Text] [Related]

  • 3. Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults.
    Ponticelli C, Passerini P.
    Clin Nephrol; 1991 Jun; 35 Suppl 1():S16-21. PubMed ID: 1860261
    [Abstract] [Full Text] [Related]

  • 4. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
    Peters HP, van de Kar NC, Wetzels JF.
    Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266
    [Abstract] [Full Text] [Related]

  • 5. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis.
    Ittel TH, Clasen W, Fuhs M, Kindler J, Mihatsch MJ, Sieberth HG.
    Clin Nephrol; 1995 Sep; 44(3):156-62. PubMed ID: 8556831
    [Abstract] [Full Text] [Related]

  • 6. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P, Frey FJ.
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [Abstract] [Full Text] [Related]

  • 7. Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: minimal-change disease and focal-segmental glomerulosclerosis. Collaborative Group of the French Society of Nephrology.
    Meyrier A, Condamin MC, Broneer D.
    Clin Nephrol; 1991 Feb; 35 Suppl 1():S37-42. PubMed ID: 1860266
    [Abstract] [Full Text] [Related]

  • 8. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 9. Cyclosporine in idiopathic nephrotic syndrome.
    Ponticelli C.
    Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):479-89. PubMed ID: 8227973
    [Abstract] [Full Text] [Related]

  • 10. Primum non nocere: Should adults with idiopathic FSGS receive steroids?
    Franceschini N, Hogan SL, Falk RJ.
    Semin Nephrol; 2003 Mar; 23(2):229-33. PubMed ID: 12704583
    [Abstract] [Full Text] [Related]

  • 11. Safety and tolerability of cyclosporin A (Sandimmun) in idiopathic nephrotic syndrome. Collaborative Study Group of Sandimmun in Nephrotic Syndrome.
    Clin Nephrol; 1991 Mar; 35 Suppl 1():S48-60. PubMed ID: 1860268
    [Abstract] [Full Text] [Related]

  • 12. Primary glomerulonephritides with nephrotic syndrome. Limitations of therapy in adult patients.
    Schena FP.
    J Nephrol; 1999 Mar; 12 Suppl 2():S125-30. PubMed ID: 10688412
    [Abstract] [Full Text] [Related]

  • 13. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A, Hill GS, Montseny JJ, Meyrier A.
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [Abstract] [Full Text] [Related]

  • 14. [Programs of immunosuppressive and anti-inflammatory treatment of primary idiopathic glomerulonephritis. I. Submicroscopic and focal segmental glomerulonephritis].
    Klinger M, Szewczyk Z.
    Przegl Lek; 1989 Jan; 46(10):744-9. PubMed ID: 2687950
    [No Abstract] [Full Text] [Related]

  • 15. Cyclosporine in glomerular disease.
    Mowry JA, McCarthy ET.
    Semin Nephrol; 1996 Nov; 16(6):548-54. PubMed ID: 9125799
    [Abstract] [Full Text] [Related]

  • 16. Treatment of idiopathic nephrotic syndrome with cyclosporine A.
    Meyrier A.
    J Nephrol; 1997 Nov; 10(1):14-24. PubMed ID: 9241620
    [Abstract] [Full Text] [Related]

  • 17. Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: a five-year follow-up study.
    Goumenos DS, Tsagalis G, El Nahas AM, Shortland JR, Davlouros P, Vlachojannis JG, Brown CB.
    Nephron Clin Pract; 2006 Nov; 104(2):c75-82. PubMed ID: 16785738
    [Abstract] [Full Text] [Related]

  • 18. Pharmacologic management of adult idiopathic nephrotic syndrome.
    Alaniz C, Brosius FC, Palmieri J.
    Clin Pharm; 1993 Jun; 12(6):429-39. PubMed ID: 8403814
    [Abstract] [Full Text] [Related]

  • 19. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
    Mahmoud I, Basuni F, Sabry A, El-Husseini A, Hassan N, Ahmad NS, Elbaz M, Moustafa F, Sobh M.
    Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265
    [Abstract] [Full Text] [Related]

  • 20. The treatment of minimal change nephrotic syndrome (lipoid nephrosis): cooperative studies of the Arbeitsgemeinschaft für Pädiatrische Nephrologie (APN).
    Brodehl J, Krohn HP, Ehrich JH.
    Klin Padiatr; 1982 Apr; 194(3):162-5. PubMed ID: 6752557
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.